Business Description
Elevance Health Inc
NAICS : 524114
SIC : 6324
ISIN : US0367521038
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 0.62 | |||||
Debt-to-EBITDA | 2.51 | |||||
Interest Coverage | 8.52 | |||||
Piotroski F-Score | 6/9 | |||||
Beneish M-Score | -2.88 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.6 | |||||
3-Year EBITDA Growth Rate | 11.2 | |||||
3-Year EPS without NRI Growth Rate | 22.4 | |||||
3-Year FCF Growth Rate | -9.2 | |||||
3-Year Book Growth Rate | 7.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 9.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.58 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 12.95 | |||||
9-Day RSI | 17.29 | |||||
14-Day RSI | 20.5 | |||||
6-1 Month Momentum % | -3.63 | |||||
12-1 Month Momentum % | 11.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.5 | |||||
Dividend Payout Ratio | 0.19 | |||||
3-Year Dividend Growth Rate | 15.9 | |||||
Forward Dividend Yield % | 1.54 | |||||
5-Year Yield-on-Cost % | 3.06 | |||||
3-Year Average Share Buyback Ratio | 1.7 | |||||
Shareholder Yield % | 1.84 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Net Margin % | 3.69 | |||||
FCF Margin % | 0.48 | |||||
ROE % | 15.71 | |||||
ROA % | 5.72 | |||||
ROIC % | 8.54 | |||||
3-Year ROIIC % | 9.22 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.31 | |||||
Forward PE Ratio | 11.36 | |||||
PE Ratio without NRI | 12.46 | |||||
Shiller PE Ratio | 19.73 | |||||
Price-to-Owner-Earnings | 435.07 | |||||
PEG Ratio | 1.14 | |||||
PS Ratio | 0.56 | |||||
PB Ratio | 2.22 | |||||
Price-to-Tangible-Book | 13.01 | |||||
Price-to-Free-Cash-Flow | 109.02 | |||||
Price-to-Operating-Cash-Flow | 45.46 | |||||
EV-to-EBIT | 12.41 | |||||
EV-to-Forward-EBIT | 10.54 | |||||
EV-to-EBITDA | 10.78 | |||||
EV-to-Forward-EBITDA | 10.07 | |||||
EV-to-Revenue | 0.67 | |||||
EV-to-Forward-Revenue | 0.62 | |||||
EV-to-FCF | 133.93 | |||||
Price-to-Projected-FCF | 0.75 | |||||
Price-to-DCF (Earnings Based) | 0.57 | |||||
Price-to-DCF (FCF Based) | 4.69 | |||||
Price-to-Median-PS-Value | 0.82 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.21 | |||||
Price-to-Graham-Number | 2.68 | |||||
Earnings Yield (Greenblatt) % | 8.06 | |||||
FCF Yield % | 0.89 | |||||
Forward Rate of Return (Yacktman) % | 17.23 |